IntelliCentrics Global Holdings Ltd. Share Price

Equities

6819

KYG480041089

Software

Market Closed - Hong Kong S.E. 09:08:35 19/04/2024 BST 5-day change 1st Jan Change
4.07 HKD 0.00% Intraday chart for IntelliCentrics Global Holdings Ltd. 0.00% +13.06%

Financials

Sales 2022 40.69M 319M 3.26B Sales 2023 43.98M 344M 3.52B Capitalization 285M 2.23B 22.84B
Net income 2022 -11M -86.11M -881M Net income 2023 -8M -62.63M -640M EV / Sales 2022 8.46 x
Net Debt 2022 11.99M 93.85M 960M Net Debt 2023 18.12M 142M 1.45B EV / Sales 2023 6.9 x
P/E ratio 2022
-28.8 x
P/E ratio 2023
-32.3 x
Employees 161
Yield 2022 *
-
Yield 2023
-
Free-Float 27.97%
More Fundamentals * Assessed data
Dynamic Chart
IntelliCentrics Global Holdings Ltd. Announces Special Interim Dividend, Payable on May 7, 2024 CI
Intellicentrics Global Holdings Ltd. Proposes Special Dividend, Payable on or Before May 7, 2024 CI
IntelliCentrics Global Delays Circular Dispatch for Sale of UK Wing MT
IntelliCentrics Global Holdings' Fiscal H1 Loss Widens MT
IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Half Year Ended December 31, 2023 CI
IntelliCentrics Arm to Sell UK Business for $246 Million MT
IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
IntelliCentrics Global's July-December 2022 Loss Narrows MT
IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Half Year Ended December 31, 2022 CI
IntelliCentrics Global Holdings Ltd. Appoints Liao Xiaoxin as Independent Non-Executive Director and Member of Audit Committee and Nomination Committee CI
IntelliCentrics Global Holdings Ltd. Announces Executive Changes CI
IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Full Year Ended June 30, 2022 CI
IntelliCentrics’ Innovations Help Drive Advanced Dallas Hospital & Clinics’ Mission of Delivering Leading Edge Medicine and Personalized Patient Care CI
IntelliCentrics enters into Strategic Alliance with Taiwanese Health Insurance Providers CI
Tranche Update on IntelliCentrics Global Holdings Ltd.'s Equity Buyback Plan announced on December 10, 2021. CI
More news
Current month+2.78%
1 month+3.56%
3 months+15.30%
6 months+11.20%
Current year+13.06%
More quotes
1 month
3.93
Extreme 3.93
4.13
Current year
3.22
Extreme 3.22
4.13
1 year
2.76
Extreme 2.76
5.02
3 years
2.76
Extreme 2.76
9.28
5 years
2.76
Extreme 2.76
9.28
10 years
2.76
Extreme 2.76
9.28
More quotes
Managers TitleAgeSince
Founder 55 02/06/16
Chief Operating Officer 59 28/02/19
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Director/Board Member 59 22/01/20
Founder 59 02/06/16
Director/Board Member 71 22/01/20
More insiders
Date Price Change Volume
19/04/24 4.07 0.00% 722,000
18/04/24 4.07 +1.24% 220,500

Delayed Quote Hong Kong S.E., April 19, 2024 at 09:08 am

More quotes
IntelliCentrics Global Holdings Ltd. operates a technology platform of trust in healthcare known as SECURE. The Company is principally engaged in the operation of a technology platform that verifies data and information. The Company provides the SECURE Ethos technology platform. The SECURE Ethos is a credentialing platform for compliance and security purposes in the healthcare industry. The platform collects, processes and verifies data and information in accordance with the different requirements of locations of care (LoCs). The Company offers two main services on the platform: vendor credentialing solution and medical credentialing solution. It has operations all over the world, including the United Kingdom, Taiwan and Canada. Its subsidiaries include Victos Holding Corp. and IntelliCentrics Zengine (Hong Kong) Company Limited. Victos Holding Corp. is an investment holding company.
More about the company